Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CTC GI and cancer staging > Cancer staging and every random thing i can think of > Flashcards

Cancer staging and every random thing i can think of Flashcards

1
Q

esophageal 1 - 4

A

critical = 3 vs 4

1 vs 2 endoscopic dx

T3 = adventitia

T 4 = invasion in to adjacent structures

T4a resectable (pleura, pericardium diphragm)

T4b NOT (trachea, aorta)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Rectal

A

Only really need T2

T3 into perirectal fat

T3 = pre-op chemo and RT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Renal

A

1 < 7cm

2 > 7cm

3 a Renal vein

3 b IVC below

3 c IVC above diaphragm

4 outside gerota or ipsi adrenal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Bladder

A

T2 muscularis propia

T3 perivesicular (outside bladder)

T4 a prostate uterus vagina

T4 b pelvic sidewall or abdominal wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Endometrial

A

Stage 1 vs 2

cervical stroma invasion (don’t see normal cervical mucosal enhancement)

pre op RT and radiacal hyst

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

cervical cancer

A

IIa vs IIb

IIa beyond cervix, no parametrial

IIb = parametrial invasion (or lower 1/3 vagine) = chemo/RT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Prostate

A

2 vs 3

extracapsular extension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

lung

unresectable =

A

unresesctable = Stage 3B (N3 or T4)

3B = supraclavicular, scalene, contra med/hilar (N3)

Same lung, diff lobe = T4

Malig pleural effusion = 3B

3B = unresectable

Diff lung = M1a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Skin doses

Early transient erythema

A

2Gy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Skin doses

Temporary epilation

A

3Gy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Skin doses

Main erythema (chronic)

A

6Gy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Skin doses

permanent hair loss

A

7Gy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Skin doses

Telangiectasia

A

10gy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Skin doses

Dry desquamation

A

13 Gy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Skin doses

Moist

A

18Gy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Skin doses

Secondary ulceration

A

24 Gy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Major spill

Tc99

A

100 mCi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Major spill

Tl 201

A

100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Major spill

In 111

A

10 mCi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Major spill

Ga 67

A

10 mCi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

I 131

A

1 mCi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

General public

annual limit

A

100 mrem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Unrestricted area

A

2mrem (.02mSv per hour) < 1mSv/7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Restricted area

A

anywhere receiving greater than 2 mrem per hour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Radiation area
\> 5 mrem (.05 mSv) in one hour at 30cm
26
High radiation area
\> 100 mrem (1mSv) in 1 hour at 30 cm
27
Very high radiation
500 rads (5 gray) in one hour at 1 meter
28
Occupational workers Lens
150 mSv per year (0.15 Sv, 15 rem)
29
Occupational workers Radiation worker
50 mSv/year (5 rem, .05 Sv)
30
Workers extremity, individual organ or tissue
500 mSv/year (50 rem, 0.5 Sv)
31
Public exposure Infrequent Continuous
5 mSv/year 1 mSv/year
32
Embryo/fetus via mother
5 mSv for pregnancy (.005 Sv, .5 rem)
33
Public exposure controlled areas
50 mSv/year
34
Public exposure uncontrolled areas
5 mSv/year
35
Genetically significant dose
0.25 mSv
36
Background US per year
3 mSv
37
White 1
no special handling surface \<0.5 mrem/hr 1 meter 0
38
Yellow 2
surface 50 mrem/hr 1 meter \<1 mrem/hr
39
Yellow 3
surface \< 200mrem/hr 1 meter \< 10 mrem/hr
40
I 123
Low 159 13 hours
41
Xe 133
Low 81 125 hours (30 seconds)
42
Thallium 201
Low 135 167 73 hours use daughter Hg x rays
43
I 111
Medium 173 247 67 hours
44
Gallium
93 184 300 393 78 hours
45
I 131
365 8 days
46
F 18
511 110 minutes
47
Strontium 89
50 days 14 days in bone
48
Samarium 153
46 hours
49
Y 90
64 hours
50
Radium 223
11.4 days
51
Radionuclide purity
how much moly Dose calibrator .15 micro per 1 milli
52
Chemical purity
How much Al pH paper \<10 micrograms per 1 ml
53
Radiochemical purity
Free Tc Thin layer chrom
54
nodal SCC neck
N1 \< 3 cm N2 (abc) 3-6 cm N3 \> 6cm
55
DOSE CALIBRATOR QC Constancy
Daily
56
DOSE CALIBRATOR QC Linearity
Quarterly
57
DOSE CALIBRATOR QC Accuracy
Annually
58
DOSE CALIBRATOR QC Geometry
Install/repair
59
1 mCi = ? Bq
1 mCi = 37 MBq
60
Packages attended to when?
within 3 hours or right away if they came overnight
61
/After making sure box not busted?
Survey and wipe
62
Wipe exceeds yellow 3?
notify carrier and NRC within 24 hours
63
Recordable vs Reportable
Report wrong patient, route, radiopharmaceutical, or \>20% prescribed IF it exceeds occupational limit 5 rem whole body (0.05 Sv) 50 mSv 50 rem body part or skin (0.5 Sv) 500 mSv Reportable = Call NRC or state within 24 hours, followed by written report Call MD and patient
64
Major spill I 123
10 mCi
65
Record keeping 3 year records of
Each radionuclide admin all receipt, storage and disposal Record of all surveys and calibrations
66
Record keeping 5 years
actions and management relative to radiation protection program
67
Permanent record
Duties, authorities and responsibilities of RSO
68
PPV 1 benchmark
4.4% 0,3,4,5
69
PPV 2
biopsy recommended 4 or 5 25.4%
70
PPV 3
31% PBR
71
Target recall rate
5-7%
72
Cancers per 1000 screened
3-8
73
Mammo Processor QC
Daily
74
Mammo Darkroom cleanliness
Daily
75
Mammo viewbox conditions
weekly
76
Mammo Phantom eval
Weekly
77
Mammo repeat analysis
Quarterly
78
mammo Compression test
SEMI annually
79
Mammo darkroom fog
semi - annually
80
Mammo screen film contrast
semi - annually
81
How often certified for MQSA by who
FDA q 3 years
82
To have honor of reading mamms?
3 months 240 during a 6 month period in last 2 years
83
ir sentinel event
15 Gy to single field
84
Male temporary
.15-2.5 Gy
85
male permanent
5 Gy
86
female 12 y
10Gy
87
Female 45y
2Gy
88
Female no age
ballpark 6 Gy
89
ARS BM
\>2Gy 1-6 week latent
90
ARS GI
\>8 Gy 5-7 day latent dead in 2 weeks
91
ARS CNS
20Gy 4-6 hours latent 3 days dead
92
Administered activities and critical organs Gallium scan
6-10 mCi Colon
93
Administered activities and critical organs Bone scan
25 mCi bladder
94
Administered activities and critical organs cysto (sulfur colloid Tc99)
1 mCi bladder
95
Administered activities and critical organs uptake and scan
5 MICRO I 131 10-20 MICRO I 123
96
Thyroid cancer I 131 doses
100 thyroid 150 nodes 200 distal
97
Critical organs I 131 MIBG
Liver
98
Critical organs Renal cortex
thallium DMSA
99
Critical organs PO sulfur colloid
Proximal colon
100
Critical organs sestamibi
proximal colon
101
Critical organs bladder
MAG 3 MDP
102
Critical organs Gallium
DISTAL colon
103
Critical organs spleen
Octreotide Damaged RBC's In-WBC's
104
Critical organs pertech
Colon estomago
105
I 123 administered activity
0.5 mCi
106
1 mCi = ? Bq
37 MBq
107
Administered activity bleeding scan Tc 99 RBC's
20-25 mCi
108
Administered activity fdg
10-20 mCi
109
Administered activity I 131 MIBG
1-2 mCi
110
Administered activity I 123 MIBG
10 mCi
111
Administered activity Tl 201
2-4 mCi
112
Administered activity resting sestimibi cardiac
7-13 mCi
113
Administered activity Sestamibi cardiac total
20-40 mCi
114
Premed protocols Pred
50mg PO PRED 13, 7 and 1 hours before 50 Benadryl 1 hr before
115
Premed protocols methylpred
32 mg methylpred PO 12 and 2 hours before 50 benadryl
116
Premed protocols rapid
200 mg hydrocortisone IV q4 until exam 50 ben 1 hr prior
117
Graves amount
10 mCi
118
MNG amount
30 mCi
119
Eovist proper name excretion other biliary guy
Gadoxetate ionic linear 50% bile, 20 mins Gadobenate, multihance, 5% bile, 2-3 hours
120
octreoscan administered activity
6 mCi
121
I 111 administered activity
0.5 mCi
122
Tl administered activity | (per oates)
3 mCi
123
administered activity I 123 Na iodide
.5 mCi
124
Gd macro vs linear ionic non ionic
macro more stable than linear of the linear, ionic more stable than nonionic
125
Gadavist other macros
Macro, non-ionic Gadobutrol teriffic 'ter's Gadoteridol - prohance Gadoterate - Dotarem
126
Linears a/w NSF
Gadodiamide - omniscan Gad*a*versetamide - optimark gadopentetate - magnevist Die, adverse, petegram the only O ones and Magnevist
127
epi IM and IV doses
IM 1:1000 0.3 ml (0.3mg) IV 1:10,000 1 ml (0.1 mg) during a code, IV epi 1:10,000 10 ml, 1 mg
128
Breast feeding and nuks cessation
I 131 I 123 NaI Gallium
129
breast feeding pertechnetate
4 hours
130
breast feeding thallium
96 hours
131
stable isotope of iodine?
I 127
132
administered activity Thyroid uptake and scan I 131 I 123 Pertech
I 131 10 MICRO I 123 0.5 mCi Pertech 2-10
133
PE, comptom Z and E
PE Z cubed / E cubed Compton 1/E (but does depend on electron density)
134
Effective dose ballparks PET Cardiac CTA chest CT head CT
PET 10 + 15 mSv Cardiac CTA 10 - 20 mSv chest CT 5 - 7 mSv head CT 1 - 2 mSv
135
? radiosensitivity
?marrow breast gonads thyroid skin
136
tube leakage should not exceed
1 mGy per hour at 1m from source
137
minimum aluminum requirement
2.5 mm
138
10 mGy in first trimester increased Ca risk
3.5 x
139
average US exposure background and medical
6 mSv 3mSv medical (mostly CT and nucs)
140
retardation organogen
retardation 9-15 organs 2-8
141
BEIR VII risk of cancer mortality
5 % per Sv
142
power for a CXR mammo
100 kW mammo 3 kW
143
kub air kerma
3 mGy
144
kub entrance skin dose PA chest lateral L spine
5 mGy (50% more than entrance air kerma) chest PA 0.2 mGy lat L spine 15 mGy
145
good dose limiting strategy for kids fatties
kids = small focal spot fatties = higher kVp
146
MTF describes
spatial resolution in the frequency domain product of component MTF's
147
Infection agent administered activities
148
Geiger is a
gas chamber
149
Well counter
na/I crystal with a PMT (small gamma camera)
150
Thyroid probe
small gamma camera, modified naI well counter (PMT and a crystal)
151
Geiger overwhelmed at
100 mR/h
152
Ion chamber
looks kinda like a Geiger, no dead time, up to 100 R/h (most dose calibrators are ion chambers, gas)
153
lp's/mm screen mammo digi mammo digi rad CT MRI
screen mammo 15 digi mammo 7 digi rad 3 CT 0.7 MRI 0.3
154
entrance exposure rate for Radiography fluoro Ir and cardiac cath
Radiography 3mGy/min fluoro 30mGy/min Ir and cardiac cath 300 mGy/min
155
File size CXR single CT image
CXR = 10 mb CT image = 0.5 mb
156
AAST Liver
grade I (tiny knick) haematoma: subcapsular, \<10% surface area laceration: capsular tear, \<1 cm parenchymal depth grade II subcapsular, 10-50% surface area laceration: capsular tear 1-3 cm parenchymal depth, \<10 cm length grade III haematoma: subcapsular, \>50% surface area of ruptured subcapsular or parenchymal haematoma laceration: capsular tear \>3 cm parenchymal depth grade IV laceration: parenchymal disruption involving 25-75% hepatic lobe or involves 1-3 Couinaud segments Grade V = vascular hepatic avulsion
157
AAST Kidney
grade I: contusion or non-enlarging subcapsular perirenal haematoma, and no laceration grade II: superficial laceration \<1 cm depth and does not involve the collecting system grade III: laceration \>1 cm without extension into the renal pelvis or collecting system (no evidence of urine extravasation) grade IV laceration extends to renal pelvis or urinary extravasation vascular: injury to main renal artery or vein with contained haemorrhage V = shattered, devascularized
158
AAST spleen
grade I subcapsular haematoma \<10% of surface area capsular laceration \<1 cm depth grade II subcapsular haematoma 10-50% of surface area intraparenchymal haematoma \<5 cm in diameter laceration 1-3 cm in depth not involving trabecular vessels grade III subcapsular haematoma \>50% of surface area or expanding intraparenchymal haematoma \>5 cm or expanding laceration \>3 cm in depth or involving trabecular vessels ruptured subcapsular or parenchymal haematoma grade IV laceration involving segmental or hilar vessels with major devascularisation (\>25% of spleen) grade V shattered spleen hilar vascular injury with splenic devascularisation

CTC GI and cancer staging (2 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions